Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-11-20
2007-11-20
Graser, Jennifer E. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S235100, C424S190100, C435S252300, C435S173300
Reexamination Certificate
active
10753980
ABSTRACT:
The present invention is directed to compounds and methods for immunizing a patient against a biofilm-producing bacterial infection and a vaccine related thereto.
REFERENCES:
patent: 4559157 (1985-12-01), Smith et al.
patent: 4608392 (1986-08-01), Jacquet et al.
patent: 4820508 (1989-04-01), Wortzman
patent: 4873192 (1989-10-01), Kunkel
patent: 4938949 (1990-07-01), Borch et al.
patent: 4992478 (1991-02-01), Geria
patent: 5336490 (1994-08-01), Brinton, Jr. et al.
patent: 6743607 (2004-06-01), Apicella et al.
patent: 7109294 (2006-09-01), O'Toole et al.
patent: WO 01/30806 (2001-05-01), None
patent: WO 03/04689 (2003-01-01), None
Altschul et al., “Basic Local Alignment Search Tool,”J. Mol. Biol., 1990, 215:403-410.
Altschul et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,”Nucl. Acids. Res., 1997, 25(17):3389-3402.
Apicella et al., “Regulation and Biosynthesis of the Biofilm of NontypeableHaemophilus influenzae,” Abstract of General Meeting of American Society for Microbiology, 2003, 103:J21.
Bandi et al., “NontypeableHaemophilus influenzaein the Lower Respiratory Tract of Patients with Chronic Bronchitis,”Am. J. Respir. Crit. Care Med., 2001, 164:2114-2119.
Barcak et al., “TwoHaemophilus influenzaeRd Genes That Complement therecA-Like Mutationrec-1,”J. Bacteriol., 1989, 171(5):2451-2457.
Batzer et al., “Enhanced evolutionary PCR using oligonucleotides with inosine at the 3'-terminus,”Nucl. Acids. Res., 1991, 19(18):5081.
Bluestone, “Current Concepts in Otolaryngology. Otitis Media in Children: To Treat or Not to Treat?”N. Engl. J. Med., 1982, 306(23):1399-1404.
Bouchet et al., “Host-derived sialic acid is incorporated intoHaemophilus influenzaelipopolysaccharide and is a major virulence factor in experimental otitis media,”Proc. Natl. Acad. Sci. USA, 2003, 100(15):8898-8903.
Burrows and Lam, “Effect ofwzx(rfbX) Mutations on A-Band and B-Band Lipopolysaccharide Biosynthesis inPseudomonas aeruginosaO5,”J. Bacteriol., 1999, 181(3):973-980.
Campagnari et al., “Antigenic Diversity of Lipooligosaccharides of NontypableHaemophilus influenzae,” Infect. Immun., 1987, 55(4):882-887.
Corpet et al., “Multiple sequence alignment with hierarchical clustering,”Nucl. Acids Res., 1988, 16(2):10881-10890.
Costerton et al., “Bacterial Biofilms : A Common Cause of Persistent Infections,”Science, 1999, 284:1318-1322.
Cox et al., “Identification and structural characterization of sialylated lacto-N-neotetraose structure in the lipopolysaccharide ofHaemophilus influenza,” Eur. J. Biochem., 2002, 269:4009-4019.
Davies and Geesey, “Regulation of the Alginate Biosynthesis GenealgCinPseudomonas aeruginosaduring Biofilm Development in Continuous Culture,”Appl. Environ. Microbiol., 1995, 61(3):860-867.
Davies et al., “Exopolysaccharide Production in Biofilms: Substratum Activation of Alginate Gene Expression byPseudomonas aeruginosa,” Appl. Environ. Microbiol., 1993, 59(4):1181-1186.
Edwards et al., “Neisseria gonorrhoeaeElicits Membrane Ruffling and Cytoskeletal Rearrangements Upon Infection of Primary Human Endocervical and Ectocervical Cells,”Infect. Immun., 2000, 68(9):5354-5363.
Ehrlich et al., “Mucosal Biofilm Formation on Middle-Ear Mucosa in the Chinchilla Model of Otitis Media,”JAMA, 2002, 287(13):1710-1715.
Fleischmann et al., “Whole-Genome Random Sequencing and Assembly ofHaemophilus influenzaeRd,”Science, 1995, 269:496-512.
Gaucher et al., “Mass Spectral Characterization of Lipooligosaccharides fromHaemophilus influenzae2019,”Biochemistry, 2000, 39:12406-12414.
Gibson et al., “Characterization of Bacterial Lipooligosaccharides by Delayed Extraction Matrix- Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry,”J. Am. Soc. Mass Spectrom., 1997, 8:645-658.
Hall-Stoodley and Stoodley, “Developmental regulation of microbial biofilms,”Curr. Opin. Biotechnol., 2002, 13:228-233.
Heydorn et al., “Quantification of biofilm structures by the novel computer program COMSTAT,”Microbiology, 2000, 146:2395-2407.
Higgins et al., “Fast and sensitive multiple sequence alignments on a microcomputer,”CABIOS, 1989, 5:151-153.
Higgins et al., “CLUSTAL: a package for performing multiple sequence alignment on a microcomputer,”Gene, 1988, 73:237-244.
Hitchcock and Brown, “Morphological Heterogeneity AmongSalmonellaLipopolysaccharide Chemotypes in Silver-Stained Polyacrylamide Gels,”J. Bacteriol., 1983, 154:269-277.
Hood et al., “Sialic acid in the lipopolysaccharide ofHaemophilus influenzae: strain distribution influence on serum resistance and structural characterization,”Mol. Microbiol., 1999, 33(4):679-692.
Hood et al., “Identification of a lipopolysaccharide α-2,3-sialyltransferase fromHaemophilus influenzae,” Mol. Microbiol., 2001, 39(2):341-350.
Hood et al., “Use of the complete genome sequence information ofHaemophilus influenzaestrain Rd to investigate lipopolysaccharide biosynthesis,”Mol. Microbiol., 1996, 22(5):951-965.
Huang et al., “Parallelization of a local similarity algorithm,”CABIOS, 1992, 8(2):155-165.
Jackson et al., “Biofilm Formation and Dispersal under the Influence of the Global Regulator CsrA ofEscherichia coli,” J. Bacteriol., 2002, 184(1):290-301.
Jones et al., “Haemophilus influenzaeType b Strain A2 Has Multiple Sialytransferases Involved in Lipooligosaccharide Sialylation,”J. Biol. Chem., 2002, 277(17):14598-14611.
Karlin and Altschul, “Applications and statistics for multiple high-scoring segments in molecular sequences,”Proc. Natl. Acad. Sci. USA, 1993, 90:5873-5877.
Karlin and Altschul, “Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes,”Proc. Natl. Acad. Sci. USA, 1990, 87:2264-2268.
Keenleyside et al., “A plasmid-encodedrfbO:54gene cluster is required for biosynthesis of the O:54 antigen inSalmonella entericaserovar Borreze,”Mol. Microbiol., 1994, 11(3):437-448.
Kirkham and Murphy, “Biofilm Formation by NontypeableHaemophilus influenzae: Strain Variability, Outer Membrane Antigen Expression and Role of Pili,”Abstracts of General Meeting of American Society for Microbiology, 2002, 102:172.
Kirkham and Murphy, “Expression of a 30kDa Peroxiredoxin Protein in Biofilms and During Human Respiratory Tract Infection byHaemophilus influenzae,” Abstracts of General Meeting of American Society for Microbiology, 2003, 103:D259.
Kunkel et al., “Rapid and Efficient Site-Specific Mutagenesis without Phenotypic Selection,”Meth. Enzymol., 1987, 154:367-382.
Kunkel, “Rapid and efficient site-specific mutagenesis without phenotypic selection,”Proc. Natl. Acad. Sci. USA, 1985, 82:488-492.
Lee et al., “Detachment ofStreptococcus mutansBiofilm Cells by an Endogenous Enzymatic Activity,”Infect. Immun., 1996, 64(3):1035-1038.
Månsson et al., “A new structral type forHaemophilus influenzaelipoplysaccharide. Structral analysis of the lipopolysaccharide from nontypeableHaemophilus influenzaestrain 486,”Eur. J. Biochem., 2001, 268:2148-2159.
Månsson et al., “Structural analysis of the lipopolysaccharide from nontypeableHaemophilus influenzaestrain 1003,”Eur. J. Biochem., 2002, 269:808-818.
Maskell et al., “Thegallocus fromHaemophilus influenzae: cloning, sequencing and the use ofgalmutants to study lipopolylsaccharide,”Mol. Microbiol., 1992, 6(20):3051-3063.
Masoud et al., “Structure of the Variable and Conserved Lipopolysaccharide Oligosaccharide Epitopes Expressed byHaemophilus influenzaeSerotype b Strain Eagan,”Biochemistry, 1997, 36:2091-2103.
McGhee et al., “New Perspectives
Graser Jennifer E.
University of Iowa Research Foundation
Viksnins Harris & Padys PLLP
LandOfFree
Vaccine and method for preventing biofilm formation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine and method for preventing biofilm formation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine and method for preventing biofilm formation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3872329